{"id":"fcm","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Injection site reactions"},{"rate":"5-10","effect":"Headache"},{"rate":"3-8","effect":"Nausea"},{"rate":"2-5","effect":"Dizziness"},{"rate":"10-20","effect":"Hypophosphatemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FCM is an intravenous iron replacement therapy that uses a carbohydrate shell to stabilize ferric iron, allowing rapid and safe delivery of iron to patients with iron deficiency. The iron is taken up by transferrin and incorporated into hemoglobin and iron storage proteins, restoring oxygen-carrying capacity and correcting anemia. This formulation enables high-dose iron administration with a favorable safety profile compared to older iron formulations.","oneSentence":"FCM (ferric carboxymaltose) delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:12:14.885Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease"},{"name":"Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron"},{"name":"Postpartum iron deficiency anemia"}]},"trialDetails":[{"nctId":"NCT07476859","phase":"PHASE4","title":"Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2026-03-05","conditions":"Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)","enrollment":538},{"nctId":"NCT01721343","phase":"NA","title":"Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-11-07","conditions":"Cognitive/Functional Effects, Malignant Neoplasm, Pain","enrollment":516},{"nctId":"NCT07468721","phase":"NA","title":"Effect of Vitamin D Supplementation on Metabolic Parameters in Patients With Type 2 Diabetes and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Faculty of Medical Sciences, Clinical Hospital","startDate":"2024-05-07","conditions":"Type 2 Diabetes Mellitus (T2DM), Vitamin D Deficiency","enrollment":119},{"nctId":"NCT04565509","phase":"NA","title":"Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-11-20","conditions":"Covid19, Intellectual Disability, Developmental Disability","enrollment":1143},{"nctId":"NCT06822751","phase":"PHASE3","title":"FOsfomycin for Male Urinary Tract Infection","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-03","conditions":"Urinary Tract Infection, Prostatitis, Cystitis","enrollment":138},{"nctId":"NCT07414199","phase":"PHASE4","title":"The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Orange County","startDate":"2026-01-31","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes, Iron Deficiency Anemia Treatment","enrollment":150},{"nctId":"NCT07359599","phase":"PHASE4","title":"The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension","status":"RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2026-01-27","conditions":"Pulmonary Hypertension, Iron Deficiency","enrollment":306},{"nctId":"NCT07370688","phase":"PHASE4","title":"Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-08-12","conditions":"Aortic Valve Stenosis, Iron Deficiency, TAVI(Transcatheter Aortic Valve Implantation)","enrollment":402},{"nctId":"NCT06440304","phase":"PHASE4","title":"Therapeutic Options for CRAB","status":"RECRUITING","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2025-01-30","conditions":"Infections, Bacterial, Sepsis Bacterial","enrollment":108},{"nctId":"NCT07355907","phase":"NA","title":"Preoperative Prophylactic Fosfomycin Trometamol Versus 5-day Levofloxacin in Prevention of Postpercutaneous Nephrolithotomy Infectious Complications and Sepsis.","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Calculi, Renal, PCNL, Infectious Complications","enrollment":210},{"nctId":"NCT05309499","phase":"NA","title":"An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function","status":"COMPLETED","sponsor":"Kazan State Medical University","startDate":"2021-12-05","conditions":"Myocardial Infarction, Iron-deficiency","enrollment":298},{"nctId":"NCT01388413","phase":"PHASE4","title":"Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2011-08","conditions":"Neurogenic Bladder, Urinary Tract Infection","enrollment":45},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT05206500","phase":"PHASE4","title":"NextGen - Clinical Implication of Next Generation Sequencing","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-05-17","conditions":"Urinary Tract Infections","enrollment":100},{"nctId":"NCT06717594","phase":"","title":"PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2023-12-01","conditions":"Gram Negative Infections, Antimicrobial Resistance (AMR)","enrollment":60},{"nctId":"NCT06958822","phase":"","title":"Ferric Carboxymaltose Methemoglobinemia Study","status":"COMPLETED","sponsor":"Ordu University","startDate":"2025-04-14","conditions":"Methemoglobinemia, Anemia, Iron-Deficiency, Parenteral Iron Therapy","enrollment":977},{"nctId":"NCT07063095","phase":"PHASE3","title":"A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections","status":"RECRUITING","sponsor":"Angela HUTTNER","startDate":"2025-08-25","conditions":"Gram Negative Infections, Sepsis and Septic Shock","enrollment":100},{"nctId":"NCT06428305","phase":"NA","title":"Providing Hygiene Education Using the Teach-back Method to Pregnant Women Diagnosed With Urinary Tract Infections","status":"COMPLETED","sponsor":"KTO Karatay University","startDate":"2024-04-22","conditions":"Urinary Tract Infections During Pregnancy","enrollment":36},{"nctId":"NCT07155590","phase":"","title":"Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2025-07-21","conditions":"Staphylococcal Aureus Infection, Staphylococcus Aureus Bacteraemia","enrollment":369},{"nctId":"NCT04959331","phase":"PHASE4","title":"Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.","status":"COMPLETED","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2021-11-02","conditions":"Urinary Tract Infections","enrollment":1000},{"nctId":"NCT05726318","phase":"PHASE4","title":"Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women","status":"COMPLETED","sponsor":"Megan Bradley","startDate":"2023-02-17","conditions":"UTI","enrollment":70},{"nctId":"NCT06882057","phase":"PHASE2, PHASE3","title":"Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-03","conditions":"Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)","enrollment":3000},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","enrollment":128},{"nctId":"NCT05759078","phase":"PHASE4","title":"Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2022-09-22","conditions":"Myocardial Infarction, Acute","enrollment":1000},{"nctId":"NCT07082465","phase":"","title":"Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand","status":"NOT_YET_RECRUITING","sponsor":"University of Oxford","startDate":"2025-08-01","conditions":"Drug Resistance, Bacterial, Bacteremia","enrollment":108000},{"nctId":"NCT07053475","phase":"PHASE4","title":"IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches","status":"RECRUITING","sponsor":"Syed Hamza Mufarrih","startDate":"2025-04-02","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":250},{"nctId":"NCT07004049","phase":"PHASE4","title":"Optimising TREATment for Severe Gram-Negative Bacterial Infections","status":"RECRUITING","sponsor":"National University of Singapore","startDate":"2025-04-21","conditions":"Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia","enrollment":600},{"nctId":"NCT01950247","phase":"PHASE4","title":"Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-08-15","conditions":"Iron Deficiency Anemia (IDA)","enrollment":1025},{"nctId":"NCT04340167","phase":"PHASE2","title":"Study of Anti-CD22 CAR-T Cells Treating Leukemia Children","status":"COMPLETED","sponsor":"Beijing Boren Hospital","startDate":"2020-05-01","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia","enrollment":14},{"nctId":"NCT06895993","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2025-04-07","conditions":"Healthy Adult","enrollment":84},{"nctId":"NCT04325841","phase":"PHASE2","title":"Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children","status":"COMPLETED","sponsor":"Beijing Boren Hospital","startDate":"2022-03-24","conditions":"Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia","enrollment":2},{"nctId":"NCT00685815","phase":"PHASE2","title":"Intravenous Iron Metabolism in Restless Legs Syndrome","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-11","conditions":"Restless Legs","enrollment":12},{"nctId":"NCT06948864","phase":"","title":"Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Cristina","startDate":"2020-01-01","conditions":"Anemia, Anemia (Iron-Loading), Perioperative Bleeding","enrollment":152},{"nctId":"NCT05816265","phase":"PHASE4","title":"Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure","status":"ENROLLING_BY_INVITATION","sponsor":"Radha Gopalan","startDate":"2024-01-24","conditions":"Heart Failure, Iron-deficiency","enrollment":40},{"nctId":"NCT02826681","phase":"PHASE2","title":"Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2017-07-10","conditions":"Restless Legs Syndrome (RLS)","enrollment":70},{"nctId":"NCT06080893","phase":"PHASE4","title":"The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2023-10-10","conditions":"Hip Fractures, Anemia, Complication,Postoperative","enrollment":209},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT06814899","phase":"","title":"Use of Fosfomycin in the Treatment of Bacterial Infections","status":"RECRUITING","sponsor":"Azienda Ospedaliera di Lecco","startDate":"2020-04-01","conditions":"Analyze the Medical Records of Patients Admitted At ASST Lecco from 01/04/2020 to 31/12/2023 Treated with Fosfomycin IV","enrollment":300},{"nctId":"NCT03036462","phase":"PHASE4","title":"Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2017-03-07","conditions":"Systolic Heart Failure, Iron Deficiency","enrollment":1105},{"nctId":"NCT06398470","phase":"PHASE1, PHASE2","title":"Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy","status":"COMPLETED","sponsor":"University College, London","startDate":"2024-05-15","conditions":"Prostate Cancer","enrollment":21},{"nctId":"NCT04340154","phase":"PHASE2","title":"Study of Sequential CAR-T Cell Treating Leukemia Children","status":"TERMINATED","sponsor":"Beijing Boren Hospital","startDate":"2020-05-01","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia","enrollment":81},{"nctId":"NCT06695832","phase":"","title":"Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2024-11-01","conditions":"Staphylococcus Aureus Bacteremia","enrollment":369},{"nctId":"NCT06419296","phase":"","title":"Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.","status":"COMPLETED","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2024-06-01","conditions":"Bacteremia","enrollment":265},{"nctId":"NCT06659016","phase":"PHASE4","title":"Efficacy of Collagen, Propolis Plus Quercetin (Proqutin®), Bacillus Coagulans, Hyaluronic Acid and Chondroitin Sulphate and D-Mannose to Avoid Symptoms and Prevents Recurrence in Women With Recurrent Urinary Tract Infections","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2023-02-01","conditions":"Urinary Tract Infection (Diagnosis)","enrollment":148},{"nctId":"NCT04882085","phase":"PHASE4","title":"Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-08-26","conditions":"Urinary Tract Infection, Acute Pyelonephritis, Hospital Acquired Pneumonia","enrollment":60},{"nctId":"NCT06651047","phase":"","title":"PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections","status":"RECRUITING","sponsor":"University of Bologna","startDate":"2024-07-09","conditions":"Gram Negative Infection, Antimicrobial Resistance (AMR)","enrollment":120},{"nctId":"NCT06017479","phase":"PHASE1, PHASE2","title":"Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-12-30","conditions":"Urological System Complication of Procedure, Urinary Tract Infections","enrollment":126},{"nctId":"NCT02979951","phase":"","title":"Fosfomycin I.v. for Treatment of Severely Infected Patients","status":"RECRUITING","sponsor":"Infectopharm Arzneimittel GmbH","startDate":"2016-12","conditions":"Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis","enrollment":1000},{"nctId":"NCT06593301","phase":"NA","title":"The Effect of Blood and Blood Products Transfusion Training Based on the Flipped Classroom Model on Nursing Students","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-02-21","conditions":"Self-efficacy","enrollment":85},{"nctId":"NCT06593444","phase":"NA","title":"Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with Epilepsy","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-09-20","conditions":"Epilepsy (treatment Refractory)","enrollment":5},{"nctId":"NCT06570850","phase":"PHASE4","title":"Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection","status":"RECRUITING","sponsor":"Chiang Mai University","startDate":"2023-04-01","conditions":"Infection Due to Carbapenem Resistant Acinetobacter","enrollment":188},{"nctId":"NCT06518291","phase":"PHASE4","title":"COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN","status":"NOT_YET_RECRUITING","sponsor":"Shalamar Institute of Health Sciences","startDate":"2025-01","conditions":"Urinary Tract Infections","enrollment":392},{"nctId":"NCT03037931","phase":"PHASE3","title":"Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2017-03-15","conditions":"Heart Failure, Iron-deficiency","enrollment":3065},{"nctId":"NCT05048693","phase":"","title":"Use of New Antibiotics in Sweden","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2021-11-01","conditions":"Multi-antibiotic Resistance","enrollment":41},{"nctId":"NCT05709028","phase":"PHASE3","title":"Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2023-08-02","conditions":"Urinary Tract Infections","enrollment":300},{"nctId":"NCT03074591","phase":"PHASE4","title":"Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-08-01","conditions":"Iron-deficiency, Heart Failure","enrollment":40},{"nctId":"NCT06080555","phase":"PHASE1","title":"Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2023-10-09","conditions":"Iron Deficiency, Anaemia","enrollment":84},{"nctId":"NCT05545137","phase":"PHASE3","title":"Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection","status":"COMPLETED","sponsor":"Benova (Tianjin) Innovative medicine Research Co., Ltd.","startDate":"2022-09-29","conditions":"Uncomplicated Urinary Tract Infection","enrollment":299},{"nctId":"NCT05519072","phase":"PHASE4","title":"Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA","status":"RECRUITING","sponsor":"Atlantic Health System","startDate":"2022-08-16","conditions":"Antibiotic Prophylaxis","enrollment":140},{"nctId":"NCT06315439","phase":"","title":"Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion","status":"COMPLETED","sponsor":"Campus Bio-Medico University","startDate":"2023-01-01","conditions":"Pancreas Adenocarcinoma, Endoscopic Ultrasound, Digital Pathology","enrollment":78},{"nctId":"NCT05226169","phase":"PHASE3","title":"Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2022-04-29","conditions":"Advanced Gastric Carcinoma","enrollment":330},{"nctId":"NCT05702970","phase":"PHASE4","title":"Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2024-01-15","conditions":"Heart Failure, Iron-deficiency, Heart Failure, Systolic","enrollment":258},{"nctId":"NCT06138444","phase":"NA","title":"Effect of Cordyceps Militaris Beverage on the Immune Response","status":"COMPLETED","sponsor":"University of Phayao","startDate":"2022-11-22","conditions":"Healthy","enrollment":40},{"nctId":"NCT03910673","phase":"PHASE1","title":"Intravenous Fosfomycin Pharmacokinetics Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-06-27","conditions":"Bacterial Infection, Multiple-drug Resistance, Pathogen Resistance","enrollment":39},{"nctId":"NCT03709914","phase":"PHASE1","title":"PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)","status":"UNKNOWN","sponsor":"Nabriva Therapeutics AG","startDate":"2018-05-24","conditions":"Pediatric ALL","enrollment":21},{"nctId":"NCT05311254","phase":"PHASE3","title":"A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia","status":"UNKNOWN","sponsor":"Fundación para la Investigación Biosanitaria del Principado de Asturias","startDate":"2022-03-14","conditions":"Febrile Neutropenia","enrollment":156},{"nctId":"NCT04312360","phase":"PHASE2","title":"Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial)","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2020-01-16","conditions":"Right-sided Colon Cancer, Right-sided Colon Adenoma","enrollment":28},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT05945667","phase":"NA","title":"Efficacy and Safety of Uronext® in Women With Cystitis","status":"COMPLETED","sponsor":"PharmaLinea Ltd.","startDate":"2021-06-07","conditions":"Cystitis","enrollment":111},{"nctId":"NCT02694978","phase":"PHASE3","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2016-02-29","conditions":"Iron Deficiency Anemia","enrollment":2014},{"nctId":"NCT04976179","phase":"PHASE3","title":"Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2021-08-09","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":1056},{"nctId":"NCT05942157","phase":"NA","title":"Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2023-03-29","conditions":"Sepsis, Hemodynamic Instability, Bacterial Infections","enrollment":810},{"nctId":"NCT00976963","phase":"NA","title":"Single Dose Monurol for Treatment of Acute Cystitis","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-09-17","conditions":"Urinary Tract Infection","enrollment":300},{"nctId":"NCT05850871","phase":"NA","title":"Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-01-06","conditions":"Carbapenem-Resistant Enterobacteriaceae Infection","enrollment":427},{"nctId":"NCT04209192","phase":"PHASE2","title":"Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2020-01-01","conditions":"Urinary Tract Infections, Bladder Cancer, Urologic Surgical Procedures","enrollment":75},{"nctId":"NCT04979832","phase":"PHASE1, PHASE2","title":"GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery","status":"UNKNOWN","sponsor":"Zealand University Hospital","startDate":"2021-09-06","conditions":"Pouchitis","enrollment":18},{"nctId":"NCT04968379","phase":"PHASE2","title":"Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia","status":"WITHDRAWN","sponsor":"American Regent, Inc.","startDate":"2022-07-21","conditions":"Iron Deficiency, Anaemia","enrollment":""},{"nctId":"NCT04083755","phase":"PHASE4","title":"Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)","status":"UNKNOWN","sponsor":"Biobizkaia Health Research Institute","startDate":"2019-08-15","conditions":"Anemia, Peripheral Arterial Occlusive Disease","enrollment":240},{"nctId":"NCT04141631","phase":"NA","title":"Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-01-13","conditions":"Cardiac Surgery, Transfusion, Perioperative Anemia","enrollment":128},{"nctId":"NCT05505006","phase":"PHASE4","title":"Management of Preoperative Anaemia in Surgical Oncology","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-03-02","conditions":"Anemia, Tumor","enrollment":500},{"nctId":"NCT05477498","phase":"PHASE4","title":"Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction","status":"WITHDRAWN","sponsor":"Cantonal Hosptal, Baselland","startDate":"2021-12-01","conditions":"Heart Failure With Normal Ejection Fraction, Iron-deficiency","enrollment":""},{"nctId":"NCT02410213","phase":"PHASE2","title":"A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2015-02-19","conditions":"Iron Deficiency Anemia (IDA)","enrollment":35},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":"Iron Deficiency Anemia","enrollment":79},{"nctId":"NCT03228108","phase":"PHASE4","title":"Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2018-04-03","conditions":"Complication, Infection, Prostate Cancer","enrollment":1538},{"nctId":"NCT01100879","phase":"PHASE4","title":"Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy","status":"TERMINATED","sponsor":"Vifor Pharma","startDate":"2010-03","conditions":"Iron-Deficiency Anemia","enrollment":3},{"nctId":"NCT05220670","phase":"NA","title":"Sarcopenia, Active Aging and Oral Microbiota. Effects of HIIT in Older Adults","status":"COMPLETED","sponsor":"University of Jaén","startDate":"2021-12-20","conditions":"Sarcopenia","enrollment":90},{"nctId":"NCT03959345","phase":"PHASE4","title":"Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia","status":"TERMINATED","sponsor":"Miquel Pujol","startDate":"2019-05-31","conditions":"Methicillin Susceptible Staphylococcus Aureus Septicemia","enrollment":215},{"nctId":"NCT04269707","phase":"PHASE3","title":"Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-11-19","conditions":"Iron Deficiency Anemia","enrollment":7},{"nctId":"NCT03803111","phase":"NA","title":"Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency","status":"WITHDRAWN","sponsor":"Herzzentrum Bremen","startDate":"2021-01-01","conditions":"Heart Failure With Reduced Ejection Fraction, Exercise Training, Ferric Carboxymaltose","enrollment":""},{"nctId":"NCT05254808","phase":"PHASE3","title":"EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care","status":"TERMINATED","sponsor":"MJM Bonten","startDate":"2021-09-06","conditions":"Urinary Tract Infections","enrollment":13},{"nctId":"NCT05260554","phase":"","title":"Effect of Cranberry Extract on the Urinary System","status":"COMPLETED","sponsor":"Kırklareli University","startDate":"2022-01-26","conditions":"Urinary Tract Disease, Cystitis, Antibiotic Reaction","enrollment":2},{"nctId":"NCT05211011","phase":"PHASE4","title":"Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2018-01-23","conditions":"Prosthetic Joint Infection","enrollment":226},{"nctId":"NCT01186640","phase":"PHASE2","title":"Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)","status":"COMPLETED","sponsor":"German CLL Study Group","startDate":"2010-06","conditions":"T-cell-prolymphocytic Leukemia","enrollment":16},{"nctId":"NCT04246021","phase":"NA","title":"Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"King Hussein Cancer Center","startDate":"2016-06-15","conditions":"Anemia, Cancer","enrollment":84},{"nctId":"NCT05055544","phase":"NA","title":"Bearberry in the Treatment of Cystitis","status":"UNKNOWN","sponsor":"University of Pecs","startDate":"2021-10","conditions":"Cystitis","enrollment":504},{"nctId":"NCT03294395","phase":"PHASE3","title":"New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea","status":"COMPLETED","sponsor":"Public Health Service of Amsterdam","startDate":"2017-09-18","conditions":"Gonorrhea","enrollment":346},{"nctId":"NCT04977895","phase":"","title":"Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2021-01-30","conditions":"B Acute Lymphoblastic Leukemia","enrollment":255},{"nctId":"NCT04974021","phase":"","title":"Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-06-20","conditions":"Ferric Carboxymaltose, Heart Failure With Reduced Ejection Fraction, Arrhythmias, Cardiac","enrollment":106},{"nctId":"NCT02937454","phase":"PHASE4","title":"Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-04-03","conditions":"Iron Deficiency, Heart Failure","enrollment":1132},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE MYELOID LEUKAEMIA"},{"count":1,"reaction":"BLOOD PRESSURE DECREASED"},{"count":1,"reaction":"CARDIAC ARREST"},{"count":1,"reaction":"CARDIO-RESPIRATORY ARREST"},{"count":1,"reaction":"UNRESPONSIVE TO STIMULI"}],"_approvalHistory":[],"publicationCount":9465,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Injectafer, Ferinject"],"phase":"phase_3","status":"active","brandName":"FCM","genericName":"FCM","companyName":"AMAG Pharmaceuticals, Inc.","companyId":"amag-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FCM (ferric carboxymaltose) delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia. Used for Iron deficiency anemia in patients with chronic kidney disease, Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron, Postpartum iron deficiency anemia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}